For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Jounce Therapeutics, Inc.

USPTO Granted Patents = 11

% Expired Patents = 9.1

EPO Patents = 2

Trademarks = 2

Forward Citations = 17

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Stephen Sazinsky (6 out of 6 patents)

Sriram Sathyanarayanan (4 out of 9 patents)

George Robert Mabry, Iii (3 out of 3 patents)

4. Kutlu Goksu Elpek (3 out of 6 patents)

5. Jennifer S Michaelson (3 out of 5 patents)

6. Heather B Cohen (2 out of 2 patents)

7. Lauren Pepper Mackenzie (2 out of 2 patents)

8. Donald Raymond Shaffer (2 out of 5 patents)

9. Jeffrey Yan-Fei Smith (2 out of 2 patents)

10. Christopher Harvey (2 out of 8 patents)

11. Heather Hirsch (1 out of 2 patents)

12. Deborah Law (1 out of 1 patent)

13. Amanda Elizabeth Hanson (1 out of 1 patent)

14. Martin Yu Fan (1 out of 1 patent)

15. Tatiana Novobrantseva (1 out of 30 patents)

11 patents: Sort by Forward Citations

1. 12729241 - ANTIBODIES THAT BIND TO HUMAN CHEMOKINE (C-C MOTIF) RECEPTOR 8 (CCR8) (2026-09-08),

2. 11905329 - Anti-PD-1 antibodies and uses thereof (2024-02-20),

3. 11384147 - Anti-PD-1 antibodies and uses thereof (2022-07-12),

4. 11359019 - Antibodies to LILRB2 (2022-06-14),

5. 11292840 - Methods of treating cancer in a subject having elevated ICOS and/or T-bet levels of CD+4 cells by administering an ICOS agonist (2022-04-05),

6. 10968277 - Gene signatures for determining ICOS expression (2021-04-06),

7. 10723798 - Antibodies to LILRB2 (2020-07-28),

8. 10654929 - Antibodies to PD-1 and uses thereof (2020-05-19),

9. 10626176 - Methods of treating conditions with antibodies that bind B7-H4 (2020-04-21),

10. 10570203 - Antibodies to ICOS (2020-02-25),

11. 10023635 - Antibodies to ICOS (2018-07-17),

Jounce Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, focused on developing innovative immunotherapies for cancer treatment. The company specializes in harnessing the immune system to target and eliminate tumors, utilizing its proprietary Jounce Therapeutics platform to identify and develop novel therapeutic candidates. With a commitment to advancing cancer care, Jounce aims to improve patient outcomes through its research in immune-oncology and related fields.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Jounce Therapeutics, Inc.

11 Patents

#216 in Cambridge, MA

#1,660 in Massachusetts

#27,470 in US

#51,671 in the World

Cambridge, MA, United States of America

Jounce Therapeutics, Inc.

Forward Citations = 17

26 inventors:

Stephen Sazinsky (6 out of 6 patents)

Sriram Sathyanarayanan (4 out of 9 patents)

George Robert Mabry, Iii (3 out of 3 patents)

4. Kutlu Goksu Elpek (3 out of 6 patents)

5. Jennifer S Michaelson (3 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…